✦ LIBER ✦

A retrospective study of pemetrexed combined with oxaliplatin as second-line treatment for advanced non-small-cell lung cancer: Comparable toxicity, better outcome

✍ Scribed by Xin-xing Zhang; Mei-juan Huang; You-ling Gong; Lin Zhou; Yong-mei Liu; Jiang Zhu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan and oxaliplatin combination a

✍ Myung Hee Chang; Kyoung Ha Kim; Hyun Jung Jun; Hyo Song Kim; Seong Yoon Yi; Ji E 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 312 KB

Pharmacogenetic study of patients with a

✍ Tiseo, Marcello; Giovannetti, Elisa; Tibaldi, Carmelo; Camerini, Andrea; Di Cost 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 285 KB

A phase II study of S-1 monotherapy as s

✍ Yoshitaka Totani; Yuji Saito; Masamichi Hayashi; Toshihiko Tada; Yasuo Kohashi; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 261 KB

Phase II study of gemcitabine plus oxali

✍ Cappuzzo, F; Novello, S; De Marinis, F; Franciosi, V; Maur, M; Ceribelli, A; Lor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Effectiveness and safety of pemetrexed-b

✍ Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Zan Shen; Yang Yao 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 366 KB

Phase II study of low-dose weekly paclit

✍ O. Juan; V. Alberola; A. Rocher; R. Casany; V. Carañana; J.M. Campos; A. Albert; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 347 KB